Features | patients analyzed | patients with aberration/s detecteda | patients with “true” aberration/sa | patients with true aberration/s on DGVa | patients with true aberration/s not on DGVa |
---|---|---|---|---|---|
HSCR form | |||||
L/TCA | 21 | 16 | 12 | 9 | 3 |
S/ultraS | 30 | 21 | 15b | 9 | 7 |
unknown | 8 | 5 | 4 | 3 | 1 |
gender | |||||
M | 42 | 29 | 23 | 16 | 7 |
F | 17 | 13 | 8b | 5 | 4 |
syndromic | |||||
no | 49 | 36 | 26b | 18 | 9 |
yes | 10 | 6 | 5 | 3 | 2 |
RET mutation | |||||
no | 45 | 31 | 22b | 17 | 6 |
yes | 14 | 11 | 9 | 4 | 5 |
5′ haplotype | |||||
risk homo | 46 | 31 | 23b | 17 | 7 |
risk het | 1 | 1 | 0 | 0 | 0 |
no risk | 6 (3 + 3) | 5 | 4 | 3 | 1 |
rare | 3 | 3 | 2 | 1 | 1 |
unknown | 3 | 2 | 2 | 0 | 2 |
tot patients | 59 | 42 | 31b | 21 | 11 |
tot aberrations | 77 (+ 6 control regions) | 37 | 25 | 12 |